- Home
- HY vs NVCT Comparison
HY vs NVCT Comparison
Compare HY & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HY | NVCT |
|---|---|---|
| Founded | 1991 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.3M | 617.7M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HY | NVCT |
|---|---|---|
| Price | $32.89 | $21.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 71.0K | ★ 168.1K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,769,300,000.00 | N/A |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | $5.29 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.41 | $5.55 |
| 52 Week High | $41.30 | $29.28 |
Technical Indicators
Market Signals| Indicator | HY | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 48.82 |
| Support Level | N/A | $17.98 |
| Resistance Level | N/A | $23.12 |
| Average True Range (ATR) | 0.00 | 1.47 |
| MACD | 0.00 | -0.26 |
| Stochastic Oscillator | 0.00 | 41.23 |
Price Performance
Historical ComparisonAbout HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells, and services a comprehensive line of lift trucks, attachments, aftermarket parts, and technology solutions marketed globally under the Hyster and Yale brand names. The company has four segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni). The majority of its revenue is generated from Lift Trucks. Geographically, it operates in America, EMEA, and JAPIC regions, of which maximum revenue is generated from its business in America, which includes lift truck operations in the U.S., Canada, Mexico, Brazil, and Latin America.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.